Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

Cancer Cell

Volumn 8, Issue 5, 2005, Pages 393-406

  Varambally, Sooryanarayana ^a   Yu, Jianjun ^a   Laxman, Bharathi ^a   Rhodes, Daniel R ^a   Mehra, Rohit ^a   Tomlins, Scott A ^a   Shah, Rajal B ^a   Chandran, Uma ^b   Monzon, Federico A ^b   Becich, Michael J ^b   Wei, John T ^a   Pienta, Kenneth J ^a   Ghosh, Debashis ^a   Rubin, Mark A ^c   Chinnaiyan, Arul M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; TISSUE EXTRACT;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; METASTASIS; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN ANALYSIS; PROTEOMICS; SOLID TUMOR; TISSUE MICROARRAY; TRANSCRIPTOMICS; TUMOR LOCALIZATION;

EID: 27644506613     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.10.001     Document Type: Article

References (61)

1. P.C. Albertsen, J.A. Hanley, D.F. Gleason, and M.J. Barry Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer JAMA 280 1998 975 980
2. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, T. Tran, and X. Yu Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511
3. N.S. Baliga, M. Pan, Y.A. Goo, E.C. Yi, D.R. Goodlett, K. Dimitrov, P. Shannon, R. Aebersold, W.V. Ng, and L. Hood Coordinate regulation of energy transduction modules in Halobacterium sp. analyzed by a global systems approach Proc. Natl. Acad. Sci. USA 99 2002 14913 14918
4. A. Bhattacharjee, W.G. Richards, J. Staunton, C. Li, S. Monti, P. Vasa, C. Ladd, J. Beheshti, R. Bueno, and M. Gillette Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses Proc. Natl. Acad. Sci. USA 98 2001 13790 13795
5. J.M. Chan, R.M. Jou, and P.R. Carroll The relative impact and future burden of prostate cancer in the United States J. Urol. 172 2004 S13 S16
6. Z. Culig, A. Hobisch, A. Hittmair, H. Peterziel, A.C. Cato, G. Bartsch, and H. Klocker Expression, structure, and function of androgen receptor in advanced prostatic carcinoma Prostate 35 1998 63 70
7. DePrimo, S.E., Diehn, M., Nelson, J.B., Reiter, R.E., Matese, J., Fero, M., Tibshirani, R., Brown, P.O., and Brooks, J.D. (2002). Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol. 3, RESEARCH0032.
8. S.M. Dhanasekaran, T.R. Barrette, D. Ghosh, R. Shah, S. Varambally, K. Kurachi, K.J. Pienta, M.A. Rubin, and A.M. Chinnaiyan Delineation of prognostic biomarkers in prostate cancer Nature 412 2001 822 826
9. K. Dobbin, and R. Simon Sample size determination in microarray experiments for class comparison and prognostic classification Biostatistics 6 2005 27 38
10. M.B. Eisen, P.T. Spellman, P.O. Brown, and D. Botstein Cluster analysis and display of genome-wide expression patterns Proc. Natl. Acad. Sci. USA 95 1998 14863 14868
11. W.A. Freije, F.E. Castro-Vargas, Z. Fang, S. Horvath, T. Cloughesy, L.M. Liau, P.S. Mischel, and S.F. Nelson Gene expression profiling of gliomas strongly predicts survival Cancer Res. 64 2004 6503 6510
12. G.V. Glinsky, A.B. Glinskii, A.J. Stephenson, R.M. Hoffman, and W.L. Gerald Gene expression profiling predicts clinical outcome of prostate cancer J. Clin. Invest. 113 2004 913 923
13. T.R. Golub, D.K. Slonim, P. Tamayo, C. Huard, M. Gaasenbeek, J.P. Mesirov, H. Coller, M.L. Loh, J.R. Downing, and M.A. Caligiuri Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 286 1999 531 537
14. T.J. Griffin, S.P. Gygi, T. Ideker, B. Rist, J. Eng, L. Hood, and R. Aebersold Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae Mol. Cell. Proteomics 1 2002 323 333
15. R.L. Grubb, V.S. Calvert, J.D. Wulkuhle, C.P. Paweletz, W.M. Linehan, J.L. Phillips, R. Chuaqui, A. Valasco, J. Gillespie, and M. Emmert-Buck Signal pathway profiling of prostate cancer using reverse phase protein arrays Proteomics 3 2003 2142 2146
16. I. Hedenfalk, D. Duggan, Y. Chen, M. Radmacher, M. Bittner, R. Simon, P. Meltzer, B. Gusterson, M. Esteller, and O.P. Kallioniemi Gene-expression profiles in hereditary breast cancer N. Engl. J. Med. 344 2001 539 548
17. T. Hirota, N. Kunitoku, T. Sasayama, T. Marumoto, D. Zhang, M. Nitta, K. Hatakeyama, and H. Saya Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells Cell 114 2003 585 598
18. L. Hood, J.R. Heath, M.E. Phelps, and B. Lin Systems biology and new technologies enable predictive and preventative medicine Science 306 2004 640 643
19. E. Huang, S.H. Cheng, H. Dressman, J. Pittman, M.H. Tsou, C.F. Horng, A. Bild, E.S. Iversen, M. Liao, and C.M. Chen Gene expression predictors of breast cancer outcomes Lancet 361 2003 1590 1596
20. Y.M. Jeng, S.Y. Peng, C.Y. Lin, and H.C. Hsu Overexpression and amplification of Aurora-A in hepatocellular carcinoma Clin. Cancer Res. 10 2004 2065 2071
21. Z. Jiang, B.A. Woda, K.L. Rock, Y. Xu, L. Savas, A. Khan, G. Pihan, F. Cai, J.S. Babcook, and P. Rathanaswami P504S: a new molecular marker for the detection of prostate carcinoma Am. J. Surg. Pathol. 25 2001 1397 1404
22. J.E. Johansson, L. Holmberg, S. Johansson, R. Bergstrom, and H.O. Adami Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden JAMA 277 1997 467 471
23. H. Katayama, K. Sasai, H. Kawai, Z.M. Yuan, J. Bondaruk, F. Suzuki, S. Fujii, R.B. Arlinghaus, B.A. Czerniak, and S. Sen Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53 Nat. Genet. 36 2004 55 62
24. C.G. Kleer, Q. Cao, S. Varambally, R. Shen, I. Ota, S.A. Tomlins, D. Ghosh, R.G. Sewalt, A.P. Otte, and D.F. Hayes EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells Proc. Natl. Acad. Sci. USA 100 2003 11606 11611
25. P. Koivisto, M. Kolmer, T. Visakorpi, and O.P. Kallioniemi Androgen receptor gene and hormonal therapy failure of prostate cancer Am. J. Pathol. 152 1998 1 9
26. J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, G. Sauter, and O.P. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat. Med. 4 1998 844 847
27. M. Krajewska, S. Krajewski, S. Banares, X. Huang, B. Turner, L. Bubendorf, O.P. Kallioniemi, A. Shabaik, A. Vitiello, and D. Peehl Elevated expression of inhibitor of apoptosis proteins in prostate cancer Clin. Cancer Res. 9 2003 4914 4925
28. C. Kumar-Sinha, and A.M. Chinnaiyan Molecular markers to identify patients at risk for recurrence after primary treatment for prostate cancer Urology Suppl. 62 2003 19 35
29. J. Lapointe, C. Li, J.P. Higgins, M. van de Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, and U. Bergerheim Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc. Natl. Acad. Sci. USA 101 2004 811 816
30. E. LaTulippe, J. Satagopan, A. Smith, H. Scher, P. Scardino, V. Reuter, and W.L. Gerald Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease Cancer Res. 62 2002 4499 4506
31. K.D. Linton, and F.C. Hamdy Early diagnosis and surgical management of prostate cancer Cancer Treat. Rev. 29 2003 151 160
32. J. Luo, D.J. Duggan, Y. Chen, J. Sauvageot, C.M. Ewing, M.L. Bittner, J.M. Trent, and W.B. Isaacs Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling Cancer Res. 61 2001 4683 4688
33. J. Luo, S. Zha, W.R. Gage, T.A. Dunn, J.L. Hicks, C.J. Bennett, C.M. Ewing, E.A. Platz, S. Ferdinandusse, and R.J. Wanders α-methylacyl-CoA racemase: a new molecular marker for prostate cancer Cancer Res. 62 2002 2220 2226
34. J.H. Luo, Y.P. Yu, K. Cieply, F. Lin, P. Deflavia, R. Dhir, S. Finkelstein, G. Michalopoulos, and M. Becich Gene expression analysis of prostate cancers Mol. Carcinog. 33 2002 25 35
35. J.A. Magee, T. Araki, S. Patil, T. Ehrig, L. True, P.A. Humphrey, W.J. Catalona, M.A. Watson, and J. Milbrandt Expression profiling reveals hepsin overexpression in prostate cancer Cancer Res. 61 2001 5692 5696
36. B.H. Mecham, G.T. Klus, J. Strovel, M. Augustus, D. Byrne, P. Bozso, D.Z. Wetmore, T.J. Mariani, I.S. Kohane, and Z. Szallasi Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements Nucleic Acids Res. 32 2004 e74
37. A.D. Mooradian, J.E. Morley, and S.G. Korenman Biological actions of androgens Endocr. Rev. 8 1987 1 28
38. K. Neben, A. Korshunov, A. Benner, G. Wrobel, M. Hahn, F. Kokocinski, A. Golanov, S. Joos, and P. Lichter Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival Cancer Res. 64 2004 3103 3111
39. P.S. Nelson, N. Clegg, H. Arnold, C. Ferguson, M. Bonham, J. White, L. Hood, and B. Lin The program of androgen-responsive genes in neoplastic prostate epithelium Proc. Natl. Acad. Sci. USA 99 2002 11890 11895
40. T.O. Nielsen, F.D. Hsu, J.X. O'Connell, C.B. Gilks, P.H. Sorensen, S. Linn, R.B. West, C.L. Liu, D. Botstein, P.O. Brown, and M. van de Rijn Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology Am. J. Pathol. 163 2003 1449 1456
41. C.P. Paweletz, L. Charboneau, V.E. Bichsel, N.L. Simone, T. Chen, J.W. Gillespie, M.R. Emmert-Buck, M.J. Roth, I.E. Petricoin, and L.A. Liotta Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front Oncogene 20 2001 1981 1989
42. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, and L.A. Akslen Molecular portraits of human breast tumours Nature 406 2000 747 752
43. E.F. Petricoin III, D.K. Ornstein, C.P. Paweletz, A. Ardekani, P.S. Hackett, B.A. Hitt, A. Velassco, C. Trucco, L. Wiegand, and K. Wood Serum proteomic patterns for detection of prostate cancer J. Natl. Cancer Inst. 94 2002 1576 1578
44. S. Ramaswamy, K.N. Ross, E.S. Lander, and T.R. Golub A molecular signature of metastasis in primary solid tumors Nat. Genet. 33 2003 49 54
45. D.R. Rhodes, J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, T. Barrette, A. Pandey, and A.M. Chinnaiyan ONCOMINE: a cancer microarray database and integrated data-mining platform Neoplasia 6 2004 1 6
46. D.R. Rhodes, S. Kalyana-Sundaram, V. Mahavisno, T.R. Barrette, D. Ghosh, and A.M. Chinnaiyan Mining for regulatory programs in the cancer transcriptome Nat. Genet. 37 2005 579 583
47. M.A. Rubin, M. Zhou, S.M. Dhanasekaran, S. Varambally, T.R. Barrette, M.G. Sanda, K.J. Pienta, D. Ghosh, and A.M. Chinnaiyan α-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer JAMA 287 2002 1662 1670
48. D.C. Schultz, K. Ayyanathan, D. Negorev, G.G. Maul, and F.J. Rauscher III. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins Genes Dev. 16 2002 919 932
49. T. Segawa, M.E. Nau, L.L. Xu, R.N. Chilukuri, M. Makarem, W. Zhang, G. Petrovics, I.A. Sesterhenn, D.G. McLeod, and J.W. Moul Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells Oncogene 21 2002 8749 8758
50. R.B. Shah, R. Mehra, A.M. Chinnaiyan, R. Shen, D. Ghosh, M. Zhou, G.R. Macvicar, S. Varambally, J. Harwood, and T.A. Bismar Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program Cancer Res. 64 2004 9209 9216
51. D. Singh, P.G. Febbo, K. Ross, D.G. Jackson, J. Manola, C. Ladd, P. Tamayo, A.A. Renshaw, A.V. D'Amico, and J.P. Richie Gene expression correlates of clinical prostate cancer behavior Cancer Cell 1 2002 203 209
52. Q. Tian, S.B. Stepaniants, M. Mao, L. Weng, M.C. Feetham, M.J. Doyle, E.C. Yi, H. Dai, V. Thorsson, and J. Eng Integrated genomic and proteomic analyses of gene expression in mammalian cells Mol. Cell. Proteomics 3 2004 960 969
53. O. Troyanskaya, M. Cantor, G. Sherlock, P. Brown, T. Hastie, R. Tibshirani, D. Botstein, and R.B. Altman Missing value estimation methods for DNA microarrays Bioinformatics 17 2001 520 525
54. L.J. van 't Veer, H. Dai, M.J. van de Vijver, Y.D. He, A.A. Hart, M. Mao, H.L. Peterse, K. van der Kooy, M.J. Marton, and A.T. Witteveen Gene expression profiling predicts clinical outcome of breast cancer Nature 415 2002 530 536
55. S. Varambally, S.M. Dhanasekaran, M. Zhou, T.R. Barrette, C. Kumar-Sinha, M.G. Sanda, D. Ghosh, K.J. Pienta, R.G. Sewalt, and A.P. Otte The polycomb group protein EZH2 is involved in progression of prostate cancer Nature 419 2002 624 629
56. A.M. Velasco, K.A. Gillis, Y. Li, E.L. Brown, T.M. Sadler, M. Achilleos, L.M. Greenberger, P. Frost, W. Bai, and Y. Zhang Identification and validation of novel androgen-regulated genes in prostate cancer Endocrinology 145 2004 3913 3924
57. A. Waghray, F. Feroze, M.S. Schober, F. Yao, C. Wood, E. Puravs, M. Krause, S. Hanash, and Y.Q. Chen Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis Proteomics 1 2001 1327 1338
58. M.P. Washburn, A. Koller, G. Oshiro, R.R. Ulaszek, D. Plouffe, C. Deciu, E. Winzeler, and J.R. Yates III. Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae Proc. Natl. Acad. Sci. USA 100 2003 3107 3112
59. J.B. Welsh, L.M. Sapinoso, A.I. Su, S.G. Kern, J. Wang-Rodriguez, C.A. Moskaluk, H.F. Frierson Jr., and G.M. Hampton Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer Cancer Res. 61 2001 5974 5978
60. L.L. Xu, Y.P. Su, R. Labiche, T. Segawa, N. Shanmugam, D.G. McLeod, J.W. Moul, and S. Srivastava Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes Int. J. Cancer 92 2001 322 328
61. Y.P. Yu, D. Landsittel, L. Jing, J. Nelson, B. Ren, L. Liu, C. McDonald, R. Thomas, R. Dhir, and S. Finkelstein Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy J. Clin. Oncol. 22 2004 2790 2799